Labcorp Holdings (LH) Liabilities and Shareholders Equity (2009 - 2026)

Labcorp Holdings (LH) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $19.1 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 8.43% year-over-year to $19.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.8 billion (up 3.5% YoY) and the FY2025 annual result came in at $18.4 billion, changed 0.07% from the prior year.
• Liabilities and Shareholders Equity rose to $19.1 billion in Q1 2026 per LH's latest filing, from $18.4 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $20.7 billion in Q1 2022, with the low at $16.5 billion in Q1 2024.
• Average Liabilities and Shareholders Equity over 5 years is $18.5 billion, with a median of $18.4 billion recorded in 2024.
• The widest YoY moves for Liabilities and Shareholders Equity: up 10.22% in 2024, down 18.16% in 2024.
• Labcorp Holdings' Liabilities and Shareholders Equity stood at $20.2 billion in 2022, then declined by 17.02% to $16.7 billion in 2023, then gained by 9.89% to $18.4 billion in 2024, then rose by 0.07% to $18.4 billion in 2025, then rose by 3.78% to $19.1 billion in 2026.
• Business Quant data shows LH's Liabilities and Shareholders Equity at $19.1 billion in Q1 2026, $18.4 billion in Q4 2025, and $18.3 billion in Q3 2025.